Inflection Point Ventures has invested $500,000 in Answer Genomics, a wellness platform, during a pre-series A round of VC funding. The company plans to use the funds for genomic health research, sales and marketing, and talent expansion. CEO Rahul Ranganathan leads the company, while Dr. Balamurali AR serves as CTO.

The Indian healthcare market will experience a 22 percent CAGR growth, but India currently lacks robust global representation in genetic data. Answer Genomics strives to leverage genetic information to tackle health and lifestyle issues by collecting genetic data with consent. This data empowers the company to offer personalized health advice based on individuals' genes, medical history, microbiome, and lifestyle.

Additionally, Answer Genomics partners with corporations to enhance employee health through genomics. The company has filed for 2 patents and published research papers in various journals.

Vikram Ramasubramanian, Partner at Inflection Point Ventures, said, “Data science and genomics hold potential to enhance health and lifestyle. Answer Genomics pioneers this space by offering insights for improved quality of life.”

Rahul Ranganathan, CEO, Answer Genomics, said, “AI is revolutionizing healthcare.”